Sex, gender, and subclinical hypertensiveorgan damage—heart

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:2284–309.

CAS  PubMed  Article  Google Scholar 

Le TT, Lim V, Ibrahim R, Teo MT, Bryant J, Ang B, et al. The remodelling index risk stratifies patients with hypertensive left ventricular hypertrophy. Eur Heart J Cardiovasc Imaging. 2021;22:670–9.

PubMed  Article  Google Scholar 

Hoang K, Zhao Y, Gardin JM, Carnethon M, Mukamal K, Yanez D, et al. LV mass as a predictor of CVD events in older adults with and without metabolic syndrome and diabetes. JACC Cardiovasc Imaging. 2015;8:1007–15.

PubMed  PubMed Central  Article  Google Scholar 

Tripepi G, D’Arrigo G, Mallamaci F, London G, Tangri N, Hsu JY, et al. Prognostic values of left ventricular mass index in chronic kidney disease patients. Nephrol Dial Transpl. 2021;36:665–72.

CAS  Article  Google Scholar 

Zhang H, Hu L, Wei XJ. Prognostic value of left ventricular hypertrophy in hypertensive patients: a meta-analysis of electrocardiographic studies. Clin Hypertens. 2020;22:254–60.

Article  Google Scholar 

Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350–6.

CAS  PubMed  Article  Google Scholar 

Pierdomenico SD, Lapenna D, Cuccurullo F. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension. Am J Hypertens. 2008;21:464–70.

PubMed  Article  Google Scholar 

Sheng Y, Li M, Xu M, Zhang Y, Xu J, Huang Y, et al. Left ventricular and atrial remodelling in hypertensive patients using thresholds from international guidelines and EMINCA data. Eur Heart J Cardiovasc Imaging. 2022;23:166–74.

PubMed  Article  Google Scholar 

Ikejder Y, Sebbani M, Hendy I, Khramz M, Khatouri A, Bendriss L. Impact of arterial hypertension on left atrial size and function. Biomed Res Int. 2020;2020:2587530.

Lilja-Cyron A, Bang CN, Gerdts E, Larstorp AC, Kjeldsen SE, Julius S, et al. Aortic root dilatation in hypertensive patients with left ventricular hypertrophy-application of a new multivariate predictive model. The Life Study. Rev Cardiovasc Med. 2022;23:95.

PubMed  Article  Google Scholar 

Nakanishi K, Daimon M, Yoshida Y, Ishiwata J, Sawada N, Hirokawa M, et al. Blood pressure categorization and subclinical left ventricular dysfunction in antihypertensive medication-naive subjects. ESC Heart Fail. 2022;9:1766–74.

PubMed  PubMed Central  Article  Google Scholar 

Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation. 1997;95:1464–70.

CAS  PubMed  Article  Google Scholar 

Sivén SS, Niiranen TJ, Langén VL, Puukka PJ, Kantola IM, Jula AM. Home versus office blood pressure: longitudinal relations with left ventricular hypertrophy: the Finn-Home study. J Hypertens. 2017;35:266–71.

PubMed  Article  CAS  Google Scholar 

Nwabuo CC, Vasan RS. Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy. Curr Hypertens Rep. 2020;22:11.

PubMed  Article  Google Scholar 

Cosenso-Martin LN, Vaz-de-Melo RO, Pereira LR, Cesarino CB, Yugar-Toledo JC, Cipullo JP, et al. Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study. Eur J Med Res. 2015;20:74.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Pi M, Ye R, Han X, Armstrong B, Liu X, Chen Y, et al. Cardiovascular interactions between fibroblast growth factor-23 and angiotensin ii. Sci Rep. 2018;8:12398.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Song WH, Lin YH, Sun K, Zhang YH, Song Y, Hou LB, et al. A functional variant in the coding region of CAMTA2 is associated with left ventricular hypertrophy by affecting the activation of Nkx2.5-dependent transcription. J Hypertens. 2016;34:942–9.

CAS  PubMed  Article  Google Scholar 

Ahmad FS, Cai X, Kunkel K, Ricardo AC, Lash JP, Raj DS, et al. CRIC Study Investigators. Racial/ethnic differences in left ventricular structure and function in chronic kidney disease: The Chronic Renal Insufficiency Cohort. Am J Hypertens. 2017;30:822–9.

PubMed  PubMed Central  Article  Google Scholar 

Lucà F, Abrignani MG, Parrini I, Di Fusco SA, Giubilato S, Rao CM, et al. Update on management of cardiovascular diseases in women. J Clin Med. 2022;11:1176.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002;23:90–119.

CAS  PubMed  Article  Google Scholar 

Sabbatini AR, Kararigas G. Estrogen-related mechanisms in sex differences of hypertension and target organ damage. Biol Sex Differ. 2020;11:31.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Li S, Gupte AA. The role of estrogen in cardiac metabolism and diastolic function. Methodist Debakey Cardiovasc J. 2017;13:4–8.

PubMed  PubMed Central  Article  Google Scholar 

Pedersen LR, Kristensen AMD, Petersen SS, Vaduganathan M, Bhatt DL, Juel J, et al. Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography. J Clin Hypertens. 2020;22:1647–58.

CAS  Article  Google Scholar 

Vasan RS, Song RJ, Xanthakis V, Beiser A, DeCarli C, Mitchell GF, et al. Hypertension-mediated organ damage prevalence, correlates, and prognosis in the community. Hypertension. 2022;79:505–15.

CAS  PubMed  Article  Google Scholar 

Tanaka K, Tanaka F, Onoda T, Tanno K, Ohsawa M, Sakata K, et al. Iwate-Kenco Study Group Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population. Am J Hypertens. 2018;31:895–901.

CAS  PubMed  Article  Google Scholar 

Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, et al. Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH). Eur Heart J Cardiovasc Imaging. 2017;18:945–60.

PubMed  Article  Google Scholar 

Cuspidi C, Rescaldani M, Sala C, Negri F, Grassi G, Mancia G. Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review. J Hypertens. 2012;30:2066–73.

CAS  PubMed  Article  Google Scholar 

dos Santos JPA, Ribeiro ALP, Andrade-Junior D, Marcolino MS. Prevalence of electrocardiographic abnormalities in primary care patients according to sex and age group. A retrospective observational study. Sao Paulo Med J. 2018;136:20–8.

PubMed  Article  Google Scholar 

Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Italian Society of Hypertension. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012;26:343–9.

CAS  PubMed  Article  Google Scholar 

Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2008;51:1109–14.

CAS  PubMed  Article  Google Scholar 

de Simone G, Devereux RB, Izzo R, Girfoglio D, Lee ET, Howard BV, et al. Lack of reduction of left ventricular mass in treated hypertension: the Strong Heart Study. J Am Heart Assoc. 2013;2:e000144.

PubMed  PubMed Central  Article  Google Scholar 

Gerdts E, Izzo R, Mancusi C, Losi MA, Manzi MV, Canciello G, et al. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network). Int J Cardiol. 2018;258:257–61.

PubMed  Article  Google Scholar 

Cai A, Liu L, Zhou D, Tang S, Zhou Y, Feng Y. Influences of achieved SBP on age and sex-related left ventricular structural alteration in community hypertensive populations. J Hypertens. 2022;40:1170–8.

CAS  PubMed  Article  Google Scholar 

de Simone G, Mancusi C, Izzo R, Losi MA, Ferrara LA. Obesity and hypertensive heart disease: focus on body composition and sex difference. Diabetol Metab Syndr. 2016;8:79.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Nunez E, Arnett DK, Benjamin EJ, Oakes JM, Liebson PR, Skelton TN. Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women. Am J Cardiol. 2004;94:1383–90.

PubMed  Article  Google Scholar 

Okin PM, Gerdts E, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, et al. Losartan Intervention for Endpoint Reduction in Hypertension Study Investigators. Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy. Hypertension 2008;52:100–6.

CAS  PubMed  Article  Google Scholar 

Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 2008;51:1109–14.

CAS  PubMed  Article  Google Scholar 

Lønnebakken MT, Izzo R, Mancusi C, Gerdts E, Losi MA, Canciello G, et al. Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania Salute Network. Am Heart Assoc. 2017;6:e004152.

Voorhees AP, Han HC. Biomechanics of cardiac function. Compr Physiol. 2016;5:1623–44.

留言 (0)

沒有登入
gif